SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001607062-14-000200
Filing Date
2014-12-12
Accepted
2014-12-12 17:01:13
Documents
10
Period of Report
2014-10-31

Document Format Files

Seq Description Document Type Size
1 PERIOD ENDING 10/31/2014 10-Q gnbt10312014form10q.htm 10-Q 692607
2 EXHIBIT 31.1 gnbt10312014form10qex31_1.htm EX-31.1 9612
3 EXHIBIT 31.2 gnbt10312014form10qex31_2.htm EX-31.2 9465
4 EXHIBIT 32 gnbt10312014form10qex32.htm EX-32 4328
  Complete submission text file 0001607062-14-000200.txt   3406792

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE FILE gnbt-20141031.xml EX-101.INS 346424
6 XBRL CALCULATION FILE gnbt-20141031_cal.xml EX-101.CAL 37335
7 XBRL DEFINITION FILE gnbt-20141031_def.xml EX-101.DEF 138478
8 XBRL LABEL FILE gnbt-20141031_lab.xml EX-101.LAB 241654
9 XBRL PRESENTATION FILE gnbt-20141031_pre.xml EX-101.PRE 190830
10 XBRL SCHEMA FILE gnbt-20141031.xsd EX-101.SCH 40656
Mailing Address 33 HARBOUR SQ STE 202 TORONTO ONTARIO CA A1 M5J 2G2
Business Address 33 HARBOUR SQ STE 202 TORONTO ONTARIO CANADA A1 M5J 2G2 4163642551
GENEREX BIOTECHNOLOGY CORP (Filer) CIK: 0001059784 (see all company filings)

IRS No.: 820490211 | State of Incorp.: DE | Fiscal Year End: 0314
Type: 10-Q | Act: 34 | File No.: 000-25169 | Film No.: 141284279
SIC: 2834 Pharmaceutical Preparations